TAMPA, FL / ACCESS Newswire / September 30, 2025 / Wellgistics Health, Inc. ("Wellgistics Health" or the "Company") (NASDAQ:WGRX), a leader in...
Vous n'êtes pas connecté
TAMPA, FL / ACCESS Newswire / September 25, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the pricing of a public offering of 7,142,862 shares of common stock, together with warrants to purchase up to 7,142,862 shares of common stock at a combined public offering price of $0.70 per share and associated warrant. The warrants will have an exercise price of $0.70 per share, will be exercisable upon issuance and will expire five years thereafter. The closing of the offering is expected to occur on or about September 29, 2025, subject to the satisfaction of...
TAMPA, FL / ACCESS Newswire / September 30, 2025 / Wellgistics Health, Inc. ("Wellgistics Health" or the "Company") (NASDAQ:WGRX), a leader in...
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small...
PHOENIX–(BUSINESS WIRE)–Phoenix Education Partners, Inc. (“Phoenix Education” or the “Company”), the parent company of The University of...
SANTA CRUZ, Calif.–(BUSINESS WIRE)–Joby Aviation, Inc. (NYSE: JOBY), a company developing electric air taxis for commercial passenger service,...
Esperion's stock sinks after pricing its common stock offering at $2.50 per share, a 19% discount to the prior close.
TAMPA, FL / ACCESS Newswire / September 30,...
ANN ARBOR, Mich., Oct. 07, 2025 (GLOBE NEWSWIRE) — Esperion Therapeutics, Inc. (“Esperion”) (Nasdaq: ESPR), a commercial stage biopharmaceutical...
C3is Inc., a ship-owning company providing dry bulk and tanker seaborne transportation services, today announced the closing of its previously...
SAN ANTONIO--(BUSINESS WIRE)--#BIAF--bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW), a biotechnology company focused on the need for noninvasive...
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc....